KURA - Kura Oncology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
50,019
47,826
46,787
26,426
20,404
Selling General and Administrative
22,709
19,653
16,096
9,651
7,963
Total Operating Expenses
72,728
67,479
62,883
36,077
28,367
Operating Income or Loss
-72,728
-67,479
-62,883
-36,077
-28,367
Interest Expense
579
580
970
888
577
Total Other Income/Expenses Net
134
245
237
780
885
Income Before Tax
-68,410
-63,140
-60,447
-35,434
-27,560
Income from Continuing Operations
-68,410
-63,140
-60,447
-35,434
-27,560
Net Income
-68,410
-63,140
-60,447
-35,434
-27,560
Net Income available to common shareholders
-68,410
-63,140
-60,447
-35,434
-27,560
Basic EPS
-
-1.51
-1.72
-1.52
-1.47
Diluted EPS
-
-1.51
-1.72
-1.52
-1.47
Basic Average Shares
-
41,946
35,191
23,237
18,701
Diluted Average Shares
-
41,946
35,191
23,237
18,701
EBITDA
-
-62,560
-59,467
-34,516
-26,952